Oxervate is a prescription eye drop approved for the treatment of neurotrophic keratitis. It is suitable for adults and children ages two years and older. Oxervate is a brand-name prescription drug ...
Dompé receives FDA approval of Oxervate™ eye drops (cenegermin-bkbj ophthalmic solution), first-in-class recombinant human nerve growth factor with potential to completely heal rare neurotrophic ...
MILAN and SAN BRUNO, Calif., March 12, 2019 /PRNewswire/ -- Dompé Farmaceutici S.p.A and Dompé U.S. Inc., (collectively Dompé), announced today that the National Organization for Rare Disorders (NORD) ...
OxervateUSPackag_1534470705843-3-HR The safety and efficacy of Oxervate was evaluated in 2 independent, double-masked, randomized, multicenter, controlled clinical trials involving patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results